- ►annals.org [PDF] PS Phillips, RH Haas - Annals of internal medicine, 2003 - Am Coll Physicians TO THE EDITOR: In their Brief Communication concerning the safety of the dietary
supplement ephedra (1), Bent and colleagues compared the 2001 Toxic Event
Surveillance System (TESS) report with ephedra sales data provided to them ... Cited by 267 - Related articles - All 10 versions
I Co, I Lafayette - Annals of Internal Medicine, 2002 - Am Coll Physicians Statin-Associated Myopathy with Normal Creatine Kinase Levels ... Paul S.
Phillips, MD; Richard H. Haas, MD; Sergei Bannykh, MD, PhD; Stephanie Hathaway,
RN; Nancy L. Gray, RN; Bruce J. Kimura, MD; Georgirene D. Vladutiu, PhD; ... Related articles - All 3 versions
- ►stanford.edu [PDF] PD Thompson, P Clarkson, RH Karas - Jama, 2003 - Am Med Assoc Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are
associated with skeletal muscle complaints, including clinically important
myositis and rhabdomyolysis, mild serum creatine kinase (CK) elevations, ... Cited by 585 - Related articles - BL Direct - All 11 versions
H Päivä, KM Thelen, R Van Coster, J Smet, B … - Clinical Pharmacology & Therapeutics, 2005 - nature.com Background: Myopathy, probably caused by 3-hydroxy-3-methylglutaryl-coenzyme A
reductase inhibition in skeletal muscle, rarely occurs in patients taking
statins. This study was designed to assess the effect of high-dose statin ... Cited by 81 - Related articles - All 5 versions
JA Staffa, J Chang, L Green - The New England Journal of Medicine, 2002 - nejm.highwire.org N Engl J Med, Vol. 346, No. 7 · February 14, 2002 · www.nejm.org · ... To
the Editor: The study by Israel et al. (Sept. 27 issue) ... To the Editor:
Israel et al. observed a dose-related decline in bone density at the hip ... Cited by 382 - Related articles - All 6 versions
PD Thompson, JM Zmuda, LJ Domalik, RJ … - Metabolism, 1997 - Elsevier This study tested the hypothesis that exercise in combination with a
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor produces
greater creatine kinase (CK) elevations, an index of skeletal muscle ... Cited by 70 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org RC Pasternak, SC Smith, CN Bairey-Merz, SM … - Journal of the American College of Cardiology, 2002 - Elsevier The voluntary withdrawal of cerivastatin (Baycol) from the US market on August
8, 2001, by the manufacturer, in agreement with the Food and Drug Administration
(FDA), has prompted concern on the part of physicians and patients ... Cited by 689 - Related articles - BL Direct - All 54 versions
SK Baker, MA Tarnopolsky - Clinical and Investigative Medicine, 2001 - epe.lac-bac.gc.ca Clin Invest Med • Vol 24, no 5, octobre 2001 ... Steven K. Baker, MSc, MD
Mark A. Tarnopolsky, MD, PhD ... From the Department of Medicine, Division of
Neurol- ogy and Rehabilitation, McMaster University Medical Centre, ... Cited by 61 - Related articles - View as HTML - BL Direct - All 5 versions
CM Ballantyne, A Corsini, MH Davidson, H … - Archives of Internal Medicine, 2003 - archinte.highwire.org Emerging data suggest that the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)
reductase inhibitors (statins) offer important benefits for the large population
of individuals at high risk for coronary heart disease. This population ... Cited by 258 - Related articles - BL Direct - All 10 versions
- ►zhaoys.com [PDF] DJ Graham, JA Staffa, D Shatin, SE Andrade, … - Jama, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 341 - Related articles - BL Direct - All 10 versions
